ClinicalTrials.gov
public full text
Public Domain
Once Weekly D-cycloserine for Schizophrenia
anti-bacterial-agentscognitive-impairmentmental-disordersneuroplasticitypsychotic-disordersschizoaffective-disorderschizophrenia
This is a parallel-group, placebo-controlled trial examining the cognitive effects at weeks 1, 4, \& 8 of once-weekly oral D-cycloserine 50 mg added to a stable dose of antipsychotic for 8 weeks in adult outpatients with schizophrenia.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Clinical Trial on the Antipsychotic Properties of Cannabidiol#1280053
- Using D-cycloserine to Enhance the Benefits of Cognitive Behavioral Therapy for Schizophrenia#1171443
- Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia#1243431
- A Trial to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment#1112900
- Appropriate Use of Antipsychotics in Long-Term Care: Environmental Scan: Drugs#304920
Record · ID 1418667
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive